• Published On : Sep-2019 |
  • Pages : 163 Pages |
  • Format :

1. Executive Summary
    1.1. Market Outlook
    1.2. Analysis and Recommendations
2. Market Overview
    2.1. Market Coverage / Taxonomy
    2.2. Market Definition / Scope / Limitations
3. Market Dynamics
    3.1. Macro-Economic Factors
        3.1.1. Drivers
        3.1.2. Restraints
        3.1.3. Opportunity Analysis
        3.1.4. Trends
        3.1.5. Forecast Factors – Relevance and Impact
        3.1.6. Pipeline Analysis
        3.1.7. Disease Epidemiology
        3.1.8. Regulatory Scenario
4. Global Uveitis Treatment Market (in Value or Size in US$ Mn) Analysis 2014-2018 and Forecast, 2019-2029
    4.1. Historical Market Value (US$ Mn) Analysis, 2014-2018
    4.2. Current and Future Market Value (US$ Mn) Projections, 2019-2029
        4.2.1. Y-o-Y Growth Trend Analysis
        4.2.2. Absolute $ Opportunity Analysis
        4.2.3. Market Value Comparison
5. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Treatment Type 
    5.1. Introduction / Key Findings
    5.2. Historical Market Size (US$ Mn) Analysis By Treatment Type, 2014-2018
    5.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Treatment Type, 2019 - 2029
        5.3.1. Corticosteroids
        5.3.2. Immunosuppressant
        5.3.3. Monoclonal Antibodies
        5.3.4. Cycloplegic Agents
        5.3.5. Antivirals
        5.3.6. Antifungals
        5.3.7. Analgesic
        5.3.8. Antibiotics
    5.4. Market Attractiveness Analysis By Treatment Type 
6. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Diseases Type
    6.1. Introduction / Key Findings
    6.2. Historical Market Size (US$ Mn) Analysis By Diseases, 2014-2018
    6.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Diseases, 2019 - 2029
        6.3.1. Anterior Uveitis
        6.3.2. Posterior  Uveitis
        6.3.3. Intermediate Uveitis
        6.3.4. Panuveitis
    6.4. Market Attractiveness Analysis By Diseases
7. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Cause
    7.1. Introduction / Key Findings
    7.2. Historical Market Size (US$ Mn) Analysis By Cause, 2014-2018
    7.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Cause, 2019 - 2029
        7.3.1. Infectious Uveitis
        7.3.2. Non-infectious Uveitis
    7.4. Market Attractiveness Analysis By Cause
8. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Distribution Channel
    8.1. Introduction / Key Findings
    8.2. Historical Market Size (US$ Mn) Analysis By Distribution Channel, 2014-2018
    8.3. Current and Future Market Size (US$ Mn) Analysis and Forecast By Distribution Channel, 2019 - 2029
        8.3.1. Hospital Pharmacies
        8.3.2. Retail Pharmacies
        8.3.3. Online Pharmacies
        8.3.4. Drug Stores
    8.4. Market Attractiveness Analysis By Distribution Channel
9. Global Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029, by Region
    9.1. Introduction
    9.2. Historical Market Size (US$ Mn) Analysis By Region, 2014-2018
    9.3. Current Market Size (US$ Mn) Analysis and Forecast By Region, 2019 - 2029
        9.3.1. North America
        9.3.2. Latin America
        9.3.3. Europe
        9.3.4. Asia Pacific
        9.3.5. Middle East & Africa
    9.4. Market Attractiveness Analysis By Region
10. North America Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
    10.1. Introduction
    10.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
    10.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
        10.3.1.  By Country
            10.3.1.1. U.S.
            10.3.1.2. Canada
        10.3.2. By Treatment Type
        10.3.3. By Diseases Type
        10.3.4. By Cause
        10.3.5. By Distribution Channel
    10.4. Market Attractiveness Analysis
        10.4.1. By Country
        10.4.2. By Treatment Type
        10.4.3. By Diseases Type
        10.4.4. By Cause
        10.4.5. By Distribution Channel
11. Latin America Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
    11.1. Introduction
    11.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
    11.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
        11.3.1.  By Country
            11.3.1.1. Brazil
            11.3.1.2. Mexico
            11.3.1.3. Rest of Latin America
        11.3.2. By Treatment Type
        11.3.3. By Diseases Type
        11.3.4. By Cause
        11.3.5. By Distribution Channel
    11.4. Market Attractiveness Analysis
        11.4.1. By Country
        11.4.2. By Treatment Type
        11.4.3. By Diseases Type
        11.4.4. By Cause
        11.4.5. By Distribution Channel
12. Europe Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
    12.1. Introduction
    12.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
    12.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
        12.3.1.  By Country
            12.3.1.1. Germany
            12.3.1.2. Italy
            12.3.1.3. France
            12.3.1.4. U.K.
            12.3.1.5. Spain
            12.3.1.6. Russia
            12.3.1.7. Rest of Europe
        12.3.2. By Treatment Type
        12.3.3. By Diseases Type
        12.3.4. By Cause
        12.3.5. By Distribution Channel
    12.4. Market Attractiveness Analysis
        12.4.1. By Country
        12.4.2. By Treatment Type
        12.4.3. By Diseases Type
        12.4.4. By Cause
        12.4.5. By Distribution Channel
13. Asia Pacific Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
    13.1. Introduction
    13.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
    13.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
        13.3.1.  By Country
            13.3.1.1. Japan
            13.3.1.2. China
            13.3.1.3. India
            13.3.1.4. Australia & New Zealand
        13.3.2. By Treatment Type
        13.3.3. By Diseases Type
        13.3.4. By Cause
        13.3.5. By Distribution Channel
    13.4. Market Attractiveness Analysis
        13.4.1. By Country
        13.4.2. By Treatment Type
        13.4.3. By Diseases Type
        13.4.4. By Cause
        13.4.5. By Distribution Channel
14. Middle East and Africa Uveitis Treatment Market Analysis 2014-2018 and Forecast 2019-2029
    14.1. Introduction
    14.2. Historical Market Size (US$ Mn) Trend Analysis By Market Taxonomy, 2014-2018
    14.3. Market Size (US$ Mn) Forecast By Market Taxonomy, 2019 - 2029
        14.3.1. By Country
            14.3.1.1. GCC
            14.3.1.2. South Africa
            14.3.1.3. North Africa
            14.3.1.4. Rest of MEA
    14.4. Market Attractiveness Analysis
        14.4.1. By Country
        14.4.2. By Treatment Type
        14.4.3. By Diseases Type
        14.4.4. By Cause
        14.4.5. By Distribution Channel
15. Competition Analysis
    15.1. Competition Dashboard
    15.2. Competition Deep Dive 
        15.2.1. Allergan, Inc.
            15.2.1.1. Overview
            15.2.1.2. Product Portfolio
            15.2.1.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.1.4. Sales Footprint
            15.2.1.5. Strategy Overview
                15.2.1.5.1. Marketing Strategy
                15.2.1.5.2. Product Strategy
                15.2.1.5.3. Channel Strategy
        15.2.2. Novartis AG
            15.2.2.1. Overview
            15.2.2.2. Product Portfolio
            15.2.2.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.2.4. Sales Footprint
            15.2.2.5. Strategy Overview
                15.2.2.5.1. Marketing Strategy
                15.2.2.5.2. Product Strategy
                15.2.2.5.3. Channel Strategy
        15.2.3. Bausch Health Inc.
            15.2.3.1. Overview
            15.2.3.2. Product Portfolio
            15.2.3.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.3.4. Sales Footprint
            15.2.3.5. Strategy Overview
                15.2.3.5.1. Marketing Strategy
                15.2.3.5.2. Product Strategy
                15.2.3.5.3. Channel Strategy
        15.2.4. AbbVie Inc.
            15.2.4.1. Overview
            15.2.4.2. Product Portfolio
            15.2.4.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.4.4. Sales Footprint
            15.2.4.5. Strategy Overview
                15.2.4.5.1. Marketing Strategy
                15.2.4.5.2. Product Strategy
                15.2.4.5.3. Channel Strategy
        15.2.5. Eyegate Pharmaceuticals, Inc.
            15.2.5.1. Overview
            15.2.5.2. Product Portfolio
            15.2.5.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.5.4. Sales Footprint
            15.2.5.5. Strategy Overview
                15.2.5.5.1. Marketing Strategy
                15.2.5.5.2. Product Strategy
                15.2.5.5.3. Channel Strategy
        15.2.6. Alimera Science Inc.
            15.2.6.1. Overview
            15.2.6.2. Product Portfolio
            15.2.6.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.6.4. Sales Footprint
            15.2.6.5. Strategy Overview
                15.2.6.5.1. Marketing Strategy
                15.2.6.5.2. Product Strategy
                15.2.6.5.3. Channel Strategy
        15.2.7. EyePoint Pharmaceuticals
            15.2.7.1. Overview
            15.2.7.2. Product Portfolio
            15.2.7.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.7.4. Sales Footprint
            15.2.7.5. Strategy Overview
                15.2.7.5.1. Marketing Strategy
                15.2.7.5.2. Product Strategy
                15.2.7.5.3. Channel Strategy
        15.2.8. Santen Pharmaceuticals
            15.2.8.1. Overview
            15.2.8.2. Product Portfolio
            15.2.8.3. Profitability by Market Segments (Product/Channel/Region)
            15.2.8.4. Sales Footprint
            15.2.8.5. Strategy Overview
                15.2.8.5.1. Marketing Strategy
                15.2.8.5.2. Product Strategy
                15.2.8.5.3. Channel Strategy
16. Assumptions and Acronyms Used
17. Research Methodology


List of Tables

Table 01: Uveitis Treatment Market Value (US$ Mn) Growth Comparison
Table 02: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 03: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases Type
Table 04: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 05: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 06: Global Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Region
Table 07: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 08: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 09: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 10: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 11: North America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 12: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 13: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 14: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 15: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 16: Latin America Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 17: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 18: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 19: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 20: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 21: Europe Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 22: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 23: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 24: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 25: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 26: Asia Pacific Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel
Table 27: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Country
Table 28: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Treatment Type
Table 29: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Diseases
Table 30: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Cause
Table 31: Middle East & Africa Uveitis Treatment Market Size (US$ Mn) Analysis 2014–2018 and Forecast 2019–2029, By Distribution Channel


List of Figures

Figure 01: Global Uveitis Treatment Market Value Share By, Treatment Type, 2019 (E)
Figure 02: Global Uveitis Treatment Market Value Share By, Disease Type, 2019 (E)
Figure 03: Global Uveitis Treatment Market Value Share By, Cause, 2019 (E)
Figure 04: Global Uveitis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 05: Global Uveitis Treatment Market Value Share By, Region, 2019 (E)
Figure 06: Global Uveitis Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 07: Global Uveitis Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 08: Global Uveitis Treatment Market Absolute $ Opportunity, 2019–2029
Figure 09: Comparison December 2016 and September 2019, Y-o-Y Forecast
Figure 10: Global Uveitis Treatment Market Share Analysis (%), By Treatment Type, 2019 & 2029
Figure 11: Global Uveitis Treatment Market Y-o-Y Analysis (%), By Treatment Type, 2019–2029
Figure 12: Global Uveitis Treatment Market Attractiveness Analysis By Treatment Type, 2019–2029
Figure 13: Global Uveitis Treatment Market Share Analysis (%), By Diseases Type, 2019 & 2029
Figure 14: Global Uveitis Treatment Market Y-o-Y Analysis (%), By Diseases Type, 2019–2029
Figure 15: Global Uveitis Treatment Market Attractiveness Analysis By Diseases Type, 2019–2029
Figure 16: Global Uveitis Treatment Market Share Analysis (%), By Cause, 2019 & 2029
Figure 17: Global Uveitis Treatment Market Y-o-Y Analysis (%), By Cause, 2019–2029
Figure 18: Global Uveitis Treatment Market Attractiveness Analysis By Cause, 2019–2029
Figure 19: Global Uveitis Treatment Market Share Analysis (%), By Distribution Channel, 2019 & 2029
Figure 20: Global Uveitis Treatment Market Y-o-Y Analysis (%), By Distribution Channel, 2019–2029
Figure 21: Global Uveitis Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 22: Global Uveitis Treatment Market Share Analysis (%), By Region Type, 2019 & 2029
Figure 23: Global Uveitis Treatment Market Y-o-Y Analysis (%), By Region Type, 2019–2029
Figure 24: Global Uveitis Treatment Market Attractiveness Analysis By Region, 2019–2029
Figure 25: North America Uveitis Treatment Market Value Share, By Treatment type, 2019 (E)
Figure 26: North America Uveitis Treatment Market Value Share, By Diseases, 2019 (E)
Figure 27: North America Uveitis Treatment Market Value Share, By Country, 2019 (E)
Figure 28: North America Uveitis Treatment Market Value Share, By Cause, 2019 (E)
Figure 29: North America Uveitis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 30: North America Uveitis Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 31: North America Uveitis Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 32: North America Uveitis Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 33: North America Uveitis Treatment Market Attractiveness Analysis By Treatment Type, 2016–2024
Figure 34: North America Uveitis Treatment Market Attractiveness Analysis By Disease Type, 2019–2029
Figure 35: North America Uveitis Treatment Market Attractiveness Analysis By Cause, 2019–2029
Figure 36: North America Uveitis Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 37: Latin America Uveitis Treatment Market Value Share, By Treatment type, 2019 (E)
Figure 38: Latin America Uveitis Treatment Market Value Share, By Diseases Type, 2019 (E)
Figure 39: Latin America Uveitis Treatment Market Value Share, By Country, 2019 (E)
Figure 40: Latin America Uveitis Treatment Market Value Share, By Cause, 2019 (E)
Figure 41: Latin America Uveitis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 42: Latin America Uveitis Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 43: Latin America Uveitis Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 44: Latin America Uveitis Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 45: Latin America Uveitis Treatment Market Attractiveness Analysis By Treatment Type, 2016–2024
Figure 46: Latin America Uveitis Treatment Market Attractiveness Analysis By Disease Type, 2019–2029
Figure 47: Latin America Uveitis Treatment Market Attractiveness Analysis By Cause, 2019–2029
Figure 48: Latin America Uveitis Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 49: Europe Uveitis Treatment Market Value Share, By Treatment type, 2019 (E)
Figure 50: Europe Uveitis Treatment Market Value Share, By Diseases Type, 2019 (E)
Figure 51: Europe Uveitis Treatment Market Value Share, By Country, 2019 (E)
Figure 52: Europe Uveitis Treatment Market Value Share, By Cause, 2019 (E)
Figure 53: Europe Uveitis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 54: Europe Uveitis Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 55: Europe Uveitis Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 56: Europe Uveitis Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 57: Europe Uveitis Treatment Market Attractiveness Analysis By Treatment Type, 2016–2024
Figure 58: Europe Uveitis Treatment Market Attractiveness Analysis By Disease Type, 2019–2029
Figure 59: Europe Uveitis Treatment Market Attractiveness Analysis By Cause, 2019–2029
Figure 60: Europe Uveitis Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 61: Asia Pacific Uveitis Treatment Market Value Share, By Treatment type, 2019 (E)
Figure 62: Asia Pacific Uveitis Treatment Market Value Share, By Diseases Type, 2019 (E)
Figure 63: Asia Pacific Uveitis Treatment Market Value Share, By Country, 2019 (E)
Figure 64: Asia Pacific Uveitis Treatment Market Value Share, By Cause, 2019 (E)
Figure 65: Asia Pacific Uveitis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 66: Asia Pacific Uveitis Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 67: Asia Pacific Uveitis Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 68: Asia Pacific Uveitis Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 69: Asia Pacific Uveitis Treatment Market Attractiveness Analysis By Treatment Type, 2016–2024
Figure 70: Asia Pacific Uveitis Treatment Market Attractiveness Analysis By Disease Type, 2019–2029
Figure 71: Asia Pacific Uveitis Treatment Market Attractiveness Analysis By Cause, 2019–2029
Figure 72: Asia Pacific Uveitis Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 73: Middle East & Africa Uveitis Treatment Market Value Share, By Treatment type, 2019 (E)
Figure 74: Middle East & Africa Uveitis Treatment Market Value Share, By Diseases type, 2019 (E)
Figure 75: Middle East & Africa Uveitis Treatment Market Value Share, By Country, 2019 (E)
Figure 76: Middle East & Africa Uveitis Treatment Market Value Share, By Cause, 2019 (E)
Figure 77: Middle East & Africa Uveitis Treatment Market Value Share, By Distribution Channel, 2019 (E)
Figure 78: Middle East & Africa Uveitis Treatment Market Value Analysis (US$ Mn), 2014–2018
Figure 79: Middle East & Africa Uveitis Treatment Market Value Forecast (US$ Mn), 2019–2029
Figure 80: Middle East & Africa Uveitis Treatment Market Attractiveness Analysis By Country, 2019–2029
Figure 81: Middle East & Africa Uveitis Treatment Market Attractiveness Analysis By Treatment Type, 2016–2024
Figure 82: Middle East & Africa Uveitis Treatment Market Attractiveness Analysis By Disease Type, 2019–2029
Figure 83: Middle East & Africa Uveitis Treatment Market Attractiveness Analysis By Cause, 2019–2029
Figure 84: Middle East & Africa Uveitis Treatment Market Attractiveness Analysis By Distribution Channel, 2019–2029
Figure 85: Global Uveitis Treatment Market: Company Share Analysis Share Analysis (2019)